These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 198634)

  • 1. Opiate receptors.
    Cox BM
    Methods Enzymol; 1977; 46():601-6. PubMed ID: 198634
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a high-affinity ligand that binds irreversibly to Mel1b melatonin receptors.
    Witt-Enderby PA; Chu GH; Gillen ML; Li PK
    J Med Chem; 1997 Dec; 40(26):4195-8. PubMed ID: 9435890
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-Hydroxy-17-aralkylmorphinans as potential opiate receptor-site-directed alkylating agents.
    Portoghese PS; Hanson RN; Telang VG; Winger JL; Takemori AE
    J Med Chem; 1977 Aug; 20(8):1020-4. PubMed ID: 197237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity labels as probes for opioid receptor types and subtypes.
    Portoghese PS; Takemori AE
    NIDA Res Monogr; 1986; 69():157-68. PubMed ID: 3020413
    [No Abstract]   [Full Text] [Related]  

  • 5. Affinity labels for beta-adrenoceptors: preparation and properties of alkylating beta-blockers derived from indole.
    Pitha J; Buchowiecki W; Milecki J; Kusiak JW
    J Med Chem; 1987 Apr; 30(4):612-5. PubMed ID: 2882025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential affinity labels for the opiate receptor based on fentanyl and related compounds.
    Maryanoff BE; Simon EJ; Gioannini T; Gorissen H
    J Med Chem; 1982 Aug; 25(8):913-9. PubMed ID: 6288945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity labeling of the nuclear vitamin D receptor with nonsteroidal alkylating agents.
    Fernández-Gacio A; Fernández-Marcos C; Swamy N; Ray R
    Bioorg Med Chem Lett; 2003 Jan; 13(2):213-6. PubMed ID: 12482426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.
    Portoghese PS; Larson DL; Sayre LM; Fries DS; Takemori AE
    J Med Chem; 1980 Mar; 23(3):233-4. PubMed ID: 6245210
    [No Abstract]   [Full Text] [Related]  

  • 9. 6beta-[N,N-Bis(2-chloroethyl)amino]-17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan(chlornaltrexamine) a potent opioid receptor alkylating agent with ultralong narcotic antagonist actitivty.
    Portoghese PS; Larson DL; Jiang JB; Takemori AE; Caruso TP
    J Med Chem; 1978 Jul; 21(7):598-9. PubMed ID: 209185
    [No Abstract]   [Full Text] [Related]  

  • 10. Naphthalene dicarboxaldehyde as an electrophilic fluorogenic moiety for affinity labeling: application to opioid receptor affinity labels with greatly improved fluorogenic properties.
    McCurdy CR; Le Bourdonnec B; Metzger TG; El Kouhen R; Zhang Y; Law PY; Portoghese PS
    J Med Chem; 2002 Jul; 45(14):2887-90. PubMed ID: 12086475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A photoaffinity reagent to label the opiate receptors of guinea pig ileum and mouse vas deferens.
    Fujioka T; Matsunaga T; Nakayama H; Kanaoka Y; Hayashi Y; Kangawa K; Matsuo H
    J Med Chem; 1984 Jul; 27(7):836-40. PubMed ID: 6330357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of highly mu and delta opioid receptor selective peptides containing a photoaffinity group.
    Landis G; Lui G; Shook JE; Yamamura HI; Burks TF; Hruby VJ
    J Med Chem; 1989 Mar; 32(3):638-43. PubMed ID: 2537426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography.
    Rothman RB; McLean S; Bykov V; Lessor RA; Jacobson AE; Rice KC; Holaday JW
    Eur J Pharmacol; 1987 Oct; 142(1):73-81. PubMed ID: 2826178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoaffinity labeling in neuroendocrine tissues.
    Hazum E
    Methods Enzymol; 1983; 103():58-71. PubMed ID: 6321897
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemically reactive estrogens: synthesis and estrogen receptor interactions of hexestrol ether derivatives and 4-substituted deoxyhexestrol derivatives bearing alkylating functions.
    Katzenellenbogen JA; McGorrin RJ; Tatee T; Kempton RJ; Carlson KE; Kinder DH
    J Med Chem; 1981 Apr; 24(4):435-50. PubMed ID: 6267281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opium alkaloids and affinity labels.
    Archer S; Bidlack J; Mulholland GK
    NIDA Res Monogr; 1990; 96():21-34. PubMed ID: 2172823
    [No Abstract]   [Full Text] [Related]  

  • 17. Photoaffinity probes for opiate receptors: synthesis and properties of a nitro-azido-derivative of 14-beta-aminomorphinone.
    Peers EM; Rance MJ; Barnard EA; Haynes AS; Smith CF
    Life Sci; 1983; 33 Suppl 1():439-42. PubMed ID: 6319900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of rat brain opioid (enkephalin) receptor by photoaffinity labeling.
    Yeung CW
    NIDA Res Monogr; 1986; 75():13-6. PubMed ID: 2828957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor.
    Galzi JL; Mejean A; Ilien B; Mollereau C; Meunier JC; Goeldner M; Hirth C
    J Med Chem; 1990 Sep; 33(9):2456-64. PubMed ID: 2167979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues.
    Sayre LM; Larson DL; Takemori AE; Portoghese PS
    J Med Chem; 1984 Oct; 27(10):1325-35. PubMed ID: 6090663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.